Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

PhRMA Seeks Repeal Of Brand Name Review Rule Until A Benefit Is Shown

Aug 08 2011

• By Cathy Dombrowski

Related Content

FDA Opens De-Regulation Docket To Collect Ideas For Repealing, Modifying Deficient Rules

Apr 26 2011

Drug Names Will Be Reviewed By FDA Within 90 Days Under PDUFA Timetable

Jan 22 2007

Dangerous Clutter: FDA Takes On Errors Caused By Drug Labels, Packaging

Jul 05 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window